At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
MRNX Defiance Daily Target 2X Long MRNA ETF
Post-Mkt 10-22 16:50:30 EDT
138.87
-74.13
-34.80%
盘后136.25
-2.62-1.89%
16:49 EDT
High203.74Low100.87Vol730.95K
Open203.61D1 Closing213.00Amplitude48.29%
Mkt Cap65.27MTradable Cap65.27MTotal Shares470.00K
T/O98.65MT/O Rate155.52%Tradable Shares470.00K
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Moderna Is About to Release the Trial Results for Its Cancer Vaccine. A Lot Is Riding on This Data
Dow Jones  ·  10-22 15:30
Moderna Is About to Release the Trial Results for Its Cancer Vaccine. A Lot Is Riding on This Data
Moderna Inc. Stock Falls 17.6%, Underperforms Peers
Dow Jones  ·  18 minutes ago
Moderna Inc. Stock Falls 17.6%, Underperforms Peers
US Equity Markets End Lower After Meta, Tesla Fail to Meet Expectations, Higher Crude Oil Prices
MT Newswires Live  ·  24 minutes ago
US Equity Markets End Lower After Meta, Tesla Fail to Meet Expectations, Higher Crude Oil Prices
US Stocks Close: Nasdaq Drops 2.6%, SOX Falls Over 6%; Jensen Huang's Remarks on Capital Shortage Spark Financing Concerns, Meta Drops 7% After Earnings
TradingKey  ·  36 minutes ago
US Stocks Close: Nasdaq Drops 2.6%, SOX Falls Over 6%; Jensen Huang's Remarks on Capital Shortage Spark Financing Concerns, Meta Drops 7% After Earnings
Moderna's Cancer Vaccine Hits Its Targets, but an Embargo Breach Rattles Investors and the Stock Tumbles
Dow Jones  ·  03:31
Moderna's Cancer Vaccine Hits Its Targets, but an Embargo Breach Rattles Investors and the Stock Tumbles
Merck, Moderna say INTerpath-001 trial data demonstrates favorable OS trend
TIPRANKS  ·  03:05
Merck, Moderna say INTerpath-001 trial data demonstrates favorable OS trend
Merck and Moderna Will Present Results from Landmark Phase 3 Interpath-001 Trial for Intismeran Autogene Plus Keytruda® (Pembrolizumab) at Esmo 2026 Presidential Symposium
THOMSON REUTERS  ·  02:59
Merck and Moderna Will Present Results from Landmark Phase 3 Interpath-001 Trial for Intismeran Autogene Plus Keytruda® (Pembrolizumab) at Esmo 2026 Presidential Symposium
Moderna Stock Is Crashing Over 20%: What Spooked Investors and What Wall Street Sees Next
TIPRANKS  ·  02:45
Moderna Stock Is Crashing Over 20%: What Spooked Investors and What Wall Street Sees Next
NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-10-22
Reuters  ·  02:45
NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-10-22
Merck/Moderna Cancer Vaccine Cuts Risk of Death or Recurrence from Melanoma by over 40%
Reuters  ·  02:25
Merck/Moderna Cancer Vaccine Cuts Risk of Death or Recurrence from Melanoma by over 40%
Moderna Plunges 25% Intraday Ahead of Full Phase 3 Melanoma Vaccine Data
TradingKey  ·  01:33
Moderna Plunges 25% Intraday Ahead of Full Phase 3 Melanoma Vaccine Data
Moderna Falls as Social Media Posts Flag Potential Cancer Vaccine Data Leak
Reuters  ·  01:31
Moderna Falls as Social Media Posts Flag Potential Cancer Vaccine Data Leak
Moderna Stock (MRNA) Plunges 25% as Data Is Leaked Online
TIPRANKS  ·  01:24
Moderna Stock (MRNA) Plunges 25% as Data Is Leaked Online
Moderna, Merck Shares Fall After Potential Data Leak for Melanoma Vaccine, Bloomberg Reports
MT Newswires Live  ·  01:22
Moderna, Merck Shares Fall After Potential Data Leak for Melanoma Vaccine, Bloomberg Reports
Moderna extends decline to 25%, Merck down 3% after alleged data leak
TIPRANKS  ·  01:20
Moderna extends decline to 25%, Merck down 3% after alleged data leak
Moderna Down over 23%, on Pace for Record Percent Decrease
Dow Jones  ·  01:18
Moderna Down over 23%, on Pace for Record Percent Decrease
Moderna volatility may be related to intismeran data
TIPRANKS  ·  00:50
Moderna volatility may be related to intismeran data
Moderna down 18% after alleged leak of melanoma vaccine data
TIPRANKS  ·  00:50
Moderna down 18% after alleged leak of melanoma vaccine data
Moderna Shares Down 13.7%
THOMSON REUTERS  ·  00:44
Moderna Shares Down 13.7%
Moderna trading resumes
TIPRANKS  ·  00:40
Moderna trading resumes

Introduction

Company Name.
Defiance Daily Target 2X Long MRNA ETF
Affiliated Markets:
ARCA
Listing Date:
--
Main Business:
Issue price:
--